Registered Olympic Designs
A standard patent can be obtained for isolated bacteria, cell lines, hybridomas, related biological materials and their use, and genetically manipulated organisms. Examples of patentable inventions include:
- isolated bacteria and other prokaryotes, fungi (including yeast), algae, protozoa, plasmids, viruses, prions
- cell lines, cell organelles, hybridomas
- genetic vectors and expression systems
- apparatus or processes for enzymology or microbiology
- compositions of micro-organisms or enzymes
- propagating, preserving or maintaining micro-organisms
- mutagenesis or genetic engineering
- fermentation or enzyme using processes to synthesise a desired compound or composition
- measuring or testing processes involving enzymes or micro-organisms
- processes using enzymes or micro-organisms to liberate, separate, purify or clean
- the use of micro-organisms to produce food or beverages.
Patents for genetic modification or manipulation
A standard patent can also be obtained for inventions involving:
- genotypically or phenotypically modified living organisms, for example, genetically modified bacteria, plants and non-human organisms (patenting of plant varieties is described in Plant Breeder's Rights)
- isolated DNA, RNA, chromosomes and genes (including human DNA and genes)
- isolated products of such DNA, RNA and genes including polypeptides and proteins.
Examples of patentable inventions include:
- synthetic genes or DNA sequences
- mutant forms and fragments of gene sequences
- an isolated DNA coding sequence for a gene
- an isolated protein expressed by a gene
- vectors (such as plasmids or bacteriophage vectors or viruses) containing a transgene
- methods of transformation using a gene
- host cells carrying a transgene
- higher plants or animals carrying a transgene
- organisms for expression of a protein from a transgene
- general recombinant DNA methods such as PCR and expression systems.
Patents for DNA or gene sequences
Human beings and the biological processes for their generation are not patentable.
Although standard patents can be obtained for biological material such as micro-organisms, nucleic acids, peptides and organelles, this material is only patentable if it has been isolated from its natural environment, or has been synthetically or recombinantly produced.
For example, DNA or genes in the human body are not patentable. A DNA or gene sequence that has been isolated may be patentable.
Patent specifications must also describe a specific use for a biological material. For example, if the invention relates to a gene, the specification must disclose a specific use for the gene, such as its use in the diagnosis or treatment of a specific disease, or its use in a specific enzymatic reaction or industrial process.
Standard patents as they apply to biological inventions
The usual requirements for a standard patent must also be met. There are also specific description requirements for micro-biological inventions:
- involves the intervention of a technologist to produce something that differs in some way from the natural source material. A patent cannot be granted for biological materials in their natural environment. For example, a biologically pure culture of a naturally occurring micro-organism or the isolation and cultivation of a naturally occurring micro-organism would satisfy the requirement for technical intervention.
- is new in the sense of not previously being publicly available. A patent cannot be granted for subject matter that has previously been made publicly available.
- is inventive when compared to the prior art.
- has been fully described in the sense that sufficient information is provided to allow someone to make the product or perform the process.
- has a demonstrated use. A patent cannot be granted for a mere discovery. The use to which the invention is to be put (for example: for the treatment of diseases such as cancer or multiple sclerosis) must also be fully described. There must be an actual use for an invention rather than speculation as to future uses.
Last Updated: 14/4/2014